Clinical Edge Journal Scan

Impact of childhood passive smoking exposure on adult-onset seropositive RA


 

Key clinical point: Passive smoking exposure in childhood is associated with adult-onset seropositive rheumatoid arthritis (RA), suggesting that early life exposures influence RA risk.

Major finding: After adjusting for confounders, maternal smoking during pregnancy was associated with all-incident RA (adjusted hazard ratio [aHR] 1.25; 95% CI 1.03-1.52) and seropositive RA (aHR 1.34; 95% CI 1.06-1.70), whereas childhood parental smoking was associated with seropositive RA (aHR 1.41; 95% CI 1.08-1.83).

Study details: This was an analysis of prospectively collected data from the Nurses’ Health Study II, involving 90,923 women.

Disclosures: This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Rheumatology Research Foundation, and National Institutes of Health. K Yoshida and J Sparks reported receiving research support and consultancy fees from various sources.

Source: Yoshida K et al. Arthritis Rheumatol. 2021 Aug 18. doi: 10.1002/art.41939 .

Recommended Reading

Fostamatinib tied to higher risk for hypertension in RA
MDedge Rheumatology
Can iguratimod be regarded as a potential alternative to methotrexate in RA?
MDedge Rheumatology
Pretreatment resistin levels tied to erosive disease risk in early RA treated with DMARD and infliximab
MDedge Rheumatology
Clinical Edge Journal Scan Commentary: RA September 2021
MDedge Rheumatology
Three JAK inhibitors get boxed warnings, modified indications
MDedge Rheumatology
Low RA flare rate reported after Pfizer COVID vaccination
MDedge Rheumatology
European agency recommends two new adalimumab biosimilars
MDedge Rheumatology
RA treatment responders show unique differences in gut microbiome
MDedge Rheumatology
Incremental benefits with filgotinib 200 mg+methotraxate in RA patients with poor prognostic factors
MDedge Rheumatology
Better outcomes with combination therapies vs. tofacitinib alone in RA patients with lesser response
MDedge Rheumatology